S. Stick (Perth, Australia), C. Benden (Zurich, Switzerland)
Amino acid concentration in bronchoalveolar lavage of young children with cystic fibrosis. A target for preventing colonisation with pseudomonas aeruginosa?
F. Horak, Jr., S. Brennan, K. Winfield, B. Lewis, L. Greed, S. M. Stick (Vienna, Austria; Perth, Australia)
|  |
Lung function, clinical status and serum/sputum IL-10 levels in CF patients
A. Korzeniewska, A. Soloniewicz, M. Bobrowska-Korzeniowska, I. Stelmach (Lodz, Poland)
| |
Sputum monocyte chemoattractant protein-1 concentration in cystic fibrosis
S. Rao, A. Wright, L. Ziegler-Heitbrock, J. Grigg (Leicester, United Kingdom)
| |
Chemokine receptors expression by T cells in cystic fibrosis
M. Funke, C. Haziza, M. Joffraud, A. Sauty (Lausanne, Switzerland)
| |
Disturbance of TGF-β-dependent T cell-mediated regulation in cystic fibrosis patients
A. L. Pukhalsky, G. V. Shmarina, D. A. Pukhalskaya, N. Y. Kashirskaya, L. V. Perederko (Moscow, Russian Federation)
| |
Th1\Th2 lymphocyte response during the course of lung infection in CF children
L. A. Jelenina, A. V. Orlov, T. V. Bulgacova, T. P. Ses (St. Petersburg, Russian Federation)
| |
The role of monocyte inflammation and oxidant stress in the etiopathogenesis of cystic fibrosis
Z. S. Uyan, G. Unluguzel, G. Haklar, E. Cakir, R. Ersu, F. Karakoc, E. Dagli (Istanbul, Turkey)
| |
The relevance of epidemic ET-12 B. cenocepacia lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other burkholderia cepacia complex species
A. De Soyza, C. Aldridge, A. Silipo, C. M. A. Khan, A. Molinaro, P. A. Corris (Newcastle upon Tyne, United Kingdom; Naples, Italy)
| |
TARC indicates ABPA in CF patients
P. Latzin, D. Hartl, M. H. Schoeni, C. Casaulta (Bern, Switzerland; Munich, Germany)
| |
Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients
I. De Schutter, E. De Wachter, C. Ernst, A. Goossens, A. Malfroot (Brussels, Belgium)
| |
Scedosporium induced deterioration and treatment in juvenile cystic fibrosis
D. E. Bock, B. H. Knöpfli, G. Schnetzler (Davos Platz, Zurich, Switzerland)
| |
Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes?
P. Schelstraete, F. De Baets, F. Haerynck, L. Van Simaey, G. Claeys, M. Vaneechoutte, S. Van daele, K. De Boeck, J. Leclercq-Foucart, P. Lebecq, A. Malfroot (Ghent, Leuven, Liege, Louvain La Neuve, Brussels, Belgium)
| |
Pseudomonas aeruginosa and legionella pneumophilia in water of dental units
J. Barben, J. Schmid (St. Gallen, Switzerland)
| |
The efficacy of early eradication therapy in prevention of chronic pseudomonas aeruginosa infection in cystic fibrosis
S. Fustik, T. Jakovska, L. Spirevska, V. Kotevska (Skopje, Fyrom)
| |
The role of ceramide in the host defense against pseudomonas aeruginosa infection
D. Korn, M. Kester, M. Basile, V. Tromba, L. Lo Russo, L. Manganozzi, S. Quattrucci, D. De Angelis, M. Battaglia, F. Midulla (Rome, Italy; Hershey, United States Of America)
| |
The general approach to cystic fibrosis in a referral respiratory hospital in Iran: necessity of prophylaxis
N. Baghaie, S. Khalilzadeh, S. S. Hakimi, M. R. Masjedi (Tehran, Islamic Republic Of Iran; Tehran, Iraq)
| |
Helicobacter pylori seroprevalence in patients with cystic fibrosis
H. Mazurek, J. Gawel, A. Pogorzelski, R. Ligarska, B. Sochan, E. Mazurek (Rabka - Zdrój, Poland)
| |